NCT01931852View on ClinicalTrials.gov

Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin

NACompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 29, 2020

Study Completion Date

October 2, 2020

Conditions
Acute Coronary SyndromeChest Pain
Interventions
PROCEDURE

Cardiac MRI

Participants in the CMR-guided care group will receive a cardiac MRI.

OTHER

ACC/AHA Guideline adherent care

Participants in the invasive-based guideline-adherent care group will receive care adherent with current American College of Cardiology / American Heart Association (ACC/AHA) guideline recommendations. ( ACC/AHA Guideline adherent care )

Trial Locations (4)

27157

Wake Forest Baptist Medical Center, Winston-Salem

39216

University of Mississippi Medical Center, Jackson

43210

The Ohio State University Wexner Medical Center, Columbus

48073

William Beaumont Hospital, Royal Oak

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01931852 - Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin | Biotech Hunter | Biotech Hunter